PA

Perceptive Advisors Portfolio holdings

AUM $2.67B
This Quarter Return
+11.69%
1 Year Return
+73.17%
3 Year Return
+837.18%
5 Year Return
+928.4%
10 Year Return
+11,818.46%
AUM
$3.38B
AUM Growth
+$3.38B
Cap. Flow
+$174M
Cap. Flow %
5.16%
Top 10 Hldgs %
46.51%
Holding
114
New
18
Increased
20
Reduced
21
Closed
14
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
ALBO
101
DELISTED
Albireo Pharma, Inc. Common Stock
ALBO
-1,757,160
Closed -$38M
ISO
102
DELISTED
IsoPlexis Corporation Common Stock
ISO
-4,095,498
Closed -$6.35M
DICE
103
DELISTED
DICE Therapeutics, Inc. Common Stock
DICE
-293,362
Closed -$9.15M
PNT
104
DELISTED
POINT Biopharma Global Inc. Common Stock
PNT
-500,000
Closed -$3.65M
RVNC
105
DELISTED
Revance Therapeutics, Inc.
RVNC
-729,097
Closed -$13.5M
NVRO
106
DELISTED
NEVRO CORP.
NVRO
-30,000
Closed -$1.19M
XBI icon
107
SPDR S&P Biotech ETF
XBI
$5.29B
0
SCPH icon
108
scPharmaceuticals
SCPH
$296M
-952,380
Closed -$6.83M
SAVA icon
109
Cassava Sciences
SAVA
$107M
0
PRVA icon
110
Privia Health
PRVA
$2.84B
-90,000
Closed -$2.04M
PRCT icon
111
Procept Biorobotics
PRCT
$2.11B
-64,537
Closed -$2.68M
PEN icon
112
Penumbra
PEN
$10.5B
-25,400
Closed -$5.65M
ACRS icon
113
Aclaris Therapeutics
ACRS
$223M
-341,239
Closed -$5.37M
ABOS icon
114
Acumen Pharmaceuticals
ABOS
$84.2M
-347,450
Closed -$1.88M